Documentos relacionados

1. Encapsulation Dynamics of Neuromuscular Blocking Drugs by Sugammadex.
2. Sugammadex--a short review and clinical recommendations for the cardiac anesthesiologist.
3. Safety, tolerability, and pharmacokinetics of adamgammadex sodium, a novel agent to reverse the action of rocuronium and vecuronium, in healthy volunteers.
4. Earlier and lower dose administration of sugammadex: A randomised placebo-controlled trial.
5. Utility of neuromuscular blockade reversal in the evaluation of acute neurosurgical patients: A retrospective case-series.
6. Safety of sugammadex for reversal of neuromuscular block: A postmarketing study based on the World Health Organization pharmacovigilance database.
7. A Dose-finding Study of Sugammadex for Reversal of Rocuronium in Cardiac Surgery Patients and Postoperative Monitoring for Recurrent Paralysis.
8. Analysis of the factors contributing to residual weakness after sugammadex administration in pediatric patients under 2 years of age.
9. Sugammadex.
10. Phase III clinical trial comparing the efficacy and safety of adamgammadex with sugammadex for reversal of rocuronium-induced neuromuscular block.